Literature DB >> 2502560

Amount, avidity, and specificity of antibodies to Pseudomonas aeruginosa in normal human sera.

J Grzybowski1, E A Trafny, J Wrembel-Wargocka, J Patzer, D Dzierzanowska, I Zawistowska-Marciniak, M Kłos.   

Abstract

Seventy-two normal human sera from healthy blood donors were tested by an enzyme-linked immunosorbent assay in order to determine the amounts and avidities of immunoglobulins M and G antibodies to lipopolysaccharides of seven Fisher's immunotypes of Pseudomonas aeruginosa and to exotoxin A. The patterns of specificity for seven immunotypes in all individual sera were determined. These data show a predominance of antibodies directed to Fisher's immunotypes 7 and 4 in the human population tested and may reflect frequency of occurrence of immunotypes outside the hospital environment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2502560      PMCID: PMC267558          DOI: 10.1128/jcm.27.6.1367-1371.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   11.677


  32 in total

1.  Toxin inhibitors of protein synthesis: production, purification, and assay of Pseudomonas aeruginosa toxin A.

Authors:  B H Iglewski; J C Sadoff
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

2.  [On the demonstration of Bact. Pyocyaneum in human material for examination].

Authors:  K LINDE; M KITTLICK
Journal:  Arch Hyg Bakteriol       Date:  1962-05

3.  Pseudomonas endocarditis: hemagglutinating antibodies to Fisher-Devlin-Gnabasik immunotypes in sera.

Authors:  M P Reyes; M W Fisher; A M Lerner
Journal:  J Lab Clin Med       Date:  1974-06

4.  IgG antibodies to phosphorylcholine exhibit more diversity than their IgM counterparts.

Authors:  P J Gearhart; N D Johnson; R Douglas; L Hood
Journal:  Nature       Date:  1981-05-07       Impact factor: 49.962

5.  Protective properties and haemagglutinins in serum from humans and in serum from mice injected with a new polyvalent Pseudomonas vaccine.

Authors:  R J Jones; E A Roe
Journal:  Br J Exp Pathol       Date:  1975-02

6.  Protective activity of antibodies to exotoxin A and lipopolysaccharide at the onset of Pseudomonas aeruginosa septicemia in man.

Authors:  M Pollack; L S Young
Journal:  J Clin Invest       Date:  1979-02       Impact factor: 14.808

7.  Pseudomonas aeruginosa antibodies in human plasma.

Authors:  T Doi; M Yoshioka; T Nakajima
Journal:  Jpn J Exp Med       Date:  1976-06

8.  Enzyme-linked immunosorbent assay for detection of Pseudomonas aeruginosa Lipopolysaccharides.

Authors:  H Kusama
Journal:  J Clin Microbiol       Date:  1983-02       Impact factor: 5.948

9.  Antibody response in patients with Pseudomonas aeruginosa infection to a 'common antigen' from P. aeruginosa analysed by means of quantitative immunoelectrophoretic methods.

Authors:  N Høiby; J B Hertz; D Sompolinsky
Journal:  Acta Pathol Microbiol Scand C       Date:  1980-06

10.  Detection by enzyme-linked immunosorbent assays of antibody specific for Pseudomonas proteases and exotoxin A in sera from cystic fibrosis patients.

Authors:  K S Jagger; D L Robinson; M N Franz; R L Warren
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 11.677

View more
  1 in total

1.  Amount and Avidity of IgG Antibodies to Pseudomonas Aeruginosa Exotoxin A Antigen in Cystic Fibrosis Patients.

Authors:  Janja Polanec; Jan Patzer; Jacek Grzybowski; Milan Strukelj; Zlatko P Pavelic
Journal:  Pathol Oncol Res       Date:  1997       Impact factor: 3.201

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.